Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer

Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer

Effective combination therapies to improve the efficacy of BET inhibitors are currently under investigation. Here, the authors examine palbociclib and paclitaxel as two promising candidates for combination therapies with BET inhibition in breast cancer and investigate the dynamics of resistance to t...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer Y. Ge, Shaokun Shu, Mijung Kwon, Bojana Jovanović, Katherine Murphy, Anushree Gulvady, Anne Fassl, Anne Trinh, Yanan Kuang, Grace A. Heavey, Adrienne Luoma, Cloud Paweletz, Aaron R. Thorner, Kai W. Wucherpfennig, Jun Qi, Myles Brown, Piotr Sicinski, Thomas O. McDonald, David Pellman, Franziska Michor, Kornelia Polyak
Format: article
Language:EN
Published: Nature Portfolio 2020
Subjects:
Science
Q
Online Access:https://doaj.org/article/c6750e9707894301940edb49bbf81051
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/c6750e9707894301940edb49bbf81051

Similar Items